Scientists have found particular cancerous cells with certain gene expressions that are specifically responsible for blood clots. SciTechDaily notes how this could be a possible anticoagulant target when it comes to treating cancer.
ALSO READ: Rare Kidney Cancer Treatment May Be Possible Through Programmed Cell Death
Genes Linked to the Most Aggressive Kidney Cancer
Findings were included in the Scientific Reports publication. It was conducted by scientists of the National Research University Higher School Economics.
The researchers discovered the genes that have specific links with clear cell renal carcinoma's most aggressive type. Data was based on the analysis of 456 kidney cancer patients. The scientists also pointed out specific subtypes that had prognoses that are both favorable and unfavorable.
Clear Cell Renal Carcinoma
Medical Xpress reports how ccRCC, or clear cell renal carcinoma, is the most prevalent kidney cancer subtype. Over the recent decades, case counts have remarkably increased. Though rich data is available about the condition, there is still a shortage of knowledge regarding the specific human genes involved and that could assist in assessing the course of the condition.
The study findings show that subtypes of ccRCC are significantly more dangerous compared to others. Genes are also seen to contribute to the disease's progression. Such new data is important when it comes to detecting aggressive tumors early on and to the designing of customized therapy plans for patients dealing with ccRCC.
Through the k-means approach for sample clustering, the cancer subtypes that had various rates of survival were pointed out. To perform the clustering of genes, researcher Grigory Puzanov chose 2,000 various genes that had differential patterns of ccRCC expressions.
Gene expression refers to the process of copying and reading a gene in order to come up with mRNA for protein synthesis.
The research was conducted in various phases. In the first stage, the characteristics of respective clusters were looked into in order to get a deeper understanding of the disease course influencers that are genetic. The researcher then pointed out specific genes for particular clusters with low and high survival and then came up with an interaction structure for specific genes that had their synthesis done by the said genes.
The analysis looked into the genes encoded that had the most connections. The cluster that had the lowest rates of survival was seen to be linked with ENAM, APOB, CP, and MFI2 genes that have acknowledged involvement in the transferring of the growth factors that is similar to insulin and in gene modification that takes place after translation. Other than this, it was also observed only among the low-survival type that genes that encoded prothrombin and fibrinogen were linked with blood clotting.
Implications for Cancer Treatment Advancements
SciTechDaily reports how some genes could affect anti-tumor treatment effectiveness. For instance, heightened activity within the genes FGA, CP, and FGG is linked with poor nivolumab response. On the other hand, high ENAM and APOB expression may lead to a lacking response to sunitinib. Such findings could enable the prescription of suitable and targeted therapies for those who have malignant cases.
The researchers note that mixing together the usage of anticoagulants and anti-tumor agents may boost cancer treatment effectiveness. Hence, heparin, a common treatment for thromboembolic events, may lead to the survival of patients and activity that is against metastasis.
RELATED ARTICLE: New Cancer Cure Can Be Lying Within Potatoes and Tomatoes, Study Suggests
Check out more news and information on Medicine and Health in Science Times.
